Stay updated on Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    New revision entry v3.5.0 was added to the record history. Revision v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-19T04:55:34.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added to the history as the latest entry, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T00:35:40.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The study title now specifies Etentamig (ABBV-383) for intravenous use in adults with relapsed or refractory multiple myeloma, with related sections added or updated accordingly.
    Difference
    0.6%
    Check dated 2026-02-18T16:27:40.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    New entry 'Revision: v3.4.2' was added to the record history. A general government operating status notice was removed from deletions.
    Difference
    0.4%
    Check dated 2026-02-11T12:34:29.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The page history shows a site-wide notice about a lapse in government funding and operation status, and an update from Revision: v3.4.0 to v3.4.1; no substantive changes to the study record content were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T06:53:39.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    The history page now uses color-coded highlights to differentiate additions and deletions and includes a revision notice (v3.4.0). A glossary toggle to show glossary terms has been added.
    Difference
    0.6%
    Check dated 2026-01-28T04:28:32.000Z thumbnail image

Stay in the know with updates to Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial page.